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Much of the research on visual hallucinations (VHs) has 
been conducted in the context of eye disease and neurode-
generative conditions, but little is known about these phe-
nomena in psychiatric and nonclinical populations. The 
purpose of this article is to bring together current knowl-
edge regarding VHs in the psychosis phenotype and contrast 
this data with the literature drawn from neurodegenerative 
disorders and eye disease. The evidence challenges the 
traditional views that VHs are atypical or uncommon in 
psychosis. The weighted mean for VHs is 27% in schizo-
phrenia, 15% in affective psychosis, and 7.3% in the general 
community. VHs are linked to a more severe psychopatho-
logical profile and less favorable outcome in psychosis and 
neurodegenerative conditions. VHs typically co-occur with 
auditory hallucinations, suggesting a common etiological 
cause. VHs in psychosis are also remarkably complex, 
negative in content, and are interpreted to have personal 
relevance. The cognitive mechanisms of VHs in psychosis 
have rarely been investigated, but existing studies point 
to source-monitoring deficits and distortions in top-down 
mechanisms, although evidence for visual processing defi-
cits, which feature strongly in the organic literature, is 
lacking. Brain imaging studies point to the activation of 
visual cortex during hallucinations on a background of 
structural and connectivity changes within wider brain 
networks. The relationship between VHs in psychosis, eye 
disease, and neurodegeneration remains unclear, although 
the pattern of similarities and differences described in this 
review suggests that comparative studies may have poten-
tially important clinical and theoretical implications.
Key words:  visual hallucinations/schizophrenia/ 
psychosis/cognition/imaging
Introduction
Hallucinations are defined in different ways by different 
philosophical traditions.1 In the clinical domain, a visual 
hallucination (VH) is a visual percept, experienced when 
awake, which is not elicited by an external stimulus. It con-
trasts with a visual illusion which is elicited by an external 
stimulus but differs from the percept normally associated 
with the stimulus. VHs occur in a wide-range of organic 
and psychiatric conditions, as well as in the absence of 
any demonstrable pathology. These experiences have been 
well described and researched in the context of organic 
disorders, particularly eye disease and neurodegenerative 
conditions such as dementia with Lewy bodies (DLB) 
and Parkinson’s disease (PD), but VHs have been largely 
neglected in psychiatric disorders and delirious states and 
in nonclinical populations.
Although the diagnostic manuals for mental disorders 
list hallucinations as a primary characteristic symptom in 
psychotic disorders, auditory hallucinations are the symp-
toms that clinicians commonly ask about. One expla-
nation lies in the traditional beliefs that VHs are more 
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common in organic states than in psychosis.2 It is also 
often difficult to decide whether the full criteria for the 
presence of VHs have been fulfilled when a range of other 
perceptual abnormalities are reported.
In this article, we review the available evidence with 
regards to the prevalence, phenomenology, clinical char-
acteristics, and assessment methods for VHs in the psy-
chosis spectrum alongside studies of cognition, brain 
imaging, electrophysiology, and treatment (cognitive 
behavioral and pharmacological). Given the lack of 
available literature on other psychiatric disorders, our 
focus is on schizophrenia, affective psychosis (ie, bipolar 
and depressive disorders), and nonclinical population 
groups (who experience VHs outside of the context of 
any psychiatric or somatic disease). The psychosis evi-
dence is compared with evidence related to eye and neu-
rodegenerative disease in the hope that similarities and 
differences between different clinical contexts will help 
our understanding of the underlying mechanisms of VH 
and its treatment.
To our knowledge, this is the first review of VH in psy-
chosis. For the first time, a cross-disciplinary and cross-
diagnostic examination of VH is also presented. Our 
broad aim is to provide a useful base for future studies on 
the topic and specifically to achieve a clearer understand-
ing of VH in psychiatric illness and greater clarity regard-
ing the assessment of VH for use in clinical practice and 
research.
Parts of this article were presented in Durham at the 
2nd International Consortium on Hallucination Research 
(ICHR) 2013 conference.3
Epidemiology
Psychosis
The centrality of VH in psychosis has been put into 
question by studies which show that auditory, and not 
visual, hallucinations are among the cardinal symptoms 
of schizophrenia which are common in all cultures.4 VHs, 
however, appear to be more frequent in schizophrenia 
than commonly thought.
Table 1 describes studies that have provided the point 
prevalence of VH in schizophrenia. Estimates vary 
widely from 4% to 65%, reflecting variations in popu-
lation and ascertainment methods. Out of 29 studies 
that have addressed this issue (5873 participants), the 
weighted mean prevalence of VH in schizophrenia is 
27% (SD  =  9). For comparison, the weighted mean of 
auditory hallucinations as provided by the same studies 
is 59% (range: 25%–86%; SD = 15), ie, twice as frequent 
as VH, although it is possible that clinician biases toward 
auditory hallucinations have skewed the results.
Psychotic symptoms such as hallucinations and delu-
sions are also a common feature of affective disorders 
including bipolar disorder.6 Table 2 shows that out of 12 
studies that differentiated between different modalities 
of hallucinations, the weighted mean frequency of VH is 
approximately 15% (range: 6%–27%, SD = 9). Similarly 
to schizophrenia, the rates of VH in bipolar disorder are 
approximately half  that of auditory hallucinations (28%).
Overall, these data challenge the assumption that VHs 
are atypical or uncommon in psychosis.
Subclinical Symptoms in the General Community
Occasional hallucinatory experiences are fairly common 
in community-living individuals. However, community 
and epidemiological studies rarely report the prevalence 
rates for VH specifically and independently from other 
hallucinatory experiences, with few exceptions. Table  3 
(A) shows that the weighted mean for VH in the general 
community is 7.3% (SD = 5, based on 6 studies).
Little is known about what distinguishes visual halluci-
nators from non-hallucinators in the general population, 
but evidence suggests that factors such as intoxication 
and withdrawal from substances such as alcohol, canna-
bis and cocaine, and other physical states such as physical 
illness and stress are linked to VH.46,47 Importantly, when 
research criteria exclude hallucinations arising from 
drug-taking or physical illness, the weighted percentages 
of hallucinations in the community reduce to 6% (see 
table 3, B).
Eye Disease and Neurodegenerative Conditions
For comparison, it is helpful to understand the epidemiol-
ogy of VH in other disorders in which VHs are common. 
The frequency estimates for VH in PD range from 15% 
to 40% (comparable to those in psychosis), and the fre-
quency roughly doubles for PD dementia (PDD) (30%–
90%) and DLB (60%–90%).48,49 In age-related eye disease, 
between 10% and 60% of patients experience complex 
VH, depending on the severity of visual loss. The most 
common eye disease associated with VH is age-related 
macular degeneration.50,51 VHs are the diagnostic crite-
rion for Charles Bonnet syndrome (CBS). Such observa-
tions have prompted many authors to suggest that VH 
arise because of dysfunctions involving visual processing.
Demographic and Clinical Characteristics
Gender
Contradictory data have emerged regarding a VH gender 
pattern in psychosis or organic illness.5,37,52,53 By contrast, 
studies in PDD and DLB do not report different frequen-
cies of VH by gender, although it is important to consider 
the gender ratio in these disorders which are more com-
mon in men than women.
Age Risk Factor and Longitudinal Course
With regards to age as a risk factor for VH in psychosis, 
some studies have demonstrated evidence that VH are 
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Table 1. The Comparative Point Prevalence of Visual and Auditory Hallucinations in Schizophrenia
Authors n
Modality of Hallucinations
Visual (%) Auditory (%)
Bowman and Raymond (1931)5 1408 22 53
Arnold (1949)6 a 14 78
Feinberg (1962)7 19 4 84
Malitz et al (1962)8 100 9 50
Vitols et al (1963)9 110 13 35
Goldberg et al (1965)10 270 18 45
Mott et al (1965)11 50 24 66
Small et al (1966)12 50 30 66
Chapman (1966)13 a 40 a
Holmboe and Astrup (1967)14 255 25 79
Jansson (1968)15 293 13 25
Goodwin et al (1971)16 45 59 82
Eggers (1973)17 a 44 71
McCabe (1976)18 40 20 36
Young (1974)19 20 45 a
Zarroug (1975)20 69 47 62
Ciompi and Müller (1976)21 a 18 58
McCabe (1976)18 25 20 52
Deiker and Chambers (1978)22 28 64 86
Huber (1979)23 a 33 75
Ndetei and Singh (1983)24 51 43 43
Ndetei (1984)25 141 15 41
Winokur et al (1985)26 140 32 78
Phillipson and Harris (1985)27 73 62 44
Bracha et al (1989)28 43 56 42
Owens and Slade (1989)29 a 29 63
Mueser et al (1990)30 117 14 71
Jablensky et al (1992)4 1288 30 55
Bauer et al (2011)31 1238 34 79
Total: 29 studies, n = 5873 participants Weighted mean = 27% Weighted mean = 59%
SD = 9.73 SD = 15.30
Note: aNot assessed or missing data.
Table 2. The Comparative Prevalence of Visual Hallucinations and Auditory Hallucinations in Bipolar and Affective Disorder
Authors n Diagnosis
Modality of Hallucinations
Visual (%) Auditory (%)
Bowman and Raymond (1931)5 1009 Mania 9 17
Rosenthal et al (1966)32 79 Mania 21 30
Winokur (1969)26 100 Mania 9 21
Goodwin et al (1971)16 28 Primary affective disorder 72 82
Taylor and Abrams (1975)33 52 Mania 23 47
Rosenthal et al (1980)34 32 Mania 25 30
Winokur (1984)26 122 Bipolar disorder 9 14
Black and Nasrallah (1989)35 467 Acute bipolar disorder 6 13
Mueser et al (1990)30 bipolar disorder 25 75
37 Severe affective disorder 10 17
Keck et al (2003)36 352 Mania 22 25
Baethge et al (2005)37 33 Manic/mixed type with 
hallucinations
27 54
32 Depressed type with 
hallucinations
25 59
Tillman et al (2008)38 549 BPD 26 57
Total: 12 studies, n = 2892 Weighted mean = 15% Weighted mean = 28%
SD = 9.75 SD = 18.11
Note: BPD = bipolar disorder.
 by guest on June 24, 2014
http://schizophreniabulletin.oxfordjournals.org/
D
ow
nloaded from
 
S236
F. Waters et al
more common in younger, compared with older, individ-
uals with schizophrenia,31,53 although negative findings 
exist.16 A similar inconsistency is found in the eye disease 
literature with only 3 of 9 studies investigating age and 
VHs reporting a weak association.51
By contrast, in nonclinical populations, the prevalence 
of VH is maximal in adolescence, and late adulthood, 
between which times the frequencies decrease.40,54 One 
explanation for increased frequency of VH with age is 
that the prevalence of most chronic disorders increases 
with age, as does the prevalence of neurodegenerative dis-
orders and age-related eye disease. In further support, the 
prevalence of death-bed visions among the dying may be 
as high as 50%.55
Thus, there appears to be a bimodal distribution of 
VH in the population with one peak in late adolescence 
and early adulthood, which is associated with psychosis, 
and a second increase in late life associated with eye and 
brain disease.
With regards to the longitudinal course, it is believed 
that hallucinations in schizophrenia tend to decrease as 
individuals age,56 although it is important to note that the 
risk of schizophrenia also declines with age.
Clinical Characteristics of VH
The presence of VH in psychosis has often been linked to 
a more severe psychopathological profile30,57 and to a less 
favorable prognosis.18 In patients with bipolar disorder, 
Baethge et al37 found that hospitalization for individuals 
with hallucinations (all modalities) averaged 17% longer 
than those who did not hallucinate.
In the general community, a link between VH and anx-
iety (OR = 5.0)41,58 and psychotic pathology (OR = 6.6)41 
has been reported. The important role of negative 
emotions in VH is illustrated in studies showing that 
stress and bereavement are linked to VH. For example, 
hallucinations of a dead spouse are common grief  reac-
tions in older adults.59
The literature in neurodegenerative disease is consis-
tent with this view of greater psychopathology in VH, 
with studies showing poorer response to treatment, 
greater mortality and morbidity, major depressive syn-
drome, and a move to institutional care.60,61
Thus, in both younger patients with psychosis and 
older patients with neurodegenerative disease, VHs are 
associated with poorer functioning and outcome. The 
same is not true of eye disease (eg, CBS) where the symp-
toms improve over time without progressive loss of cog-
nitive function.
Association With Other Symptoms
In schizophrenia, VHs typically co-occur in association 
with other hallucinations and other sensory modali-
ties.16,28,30,62 For example, it has been reported that co-
occurring visual and auditory hallucinations occur in up 
to 84% of individuals with schizophrenia.30 Furthermore, 
early evidence suggested VH never occurred in psychosis 
without the presence of auditory hallucinations (either 
at the same time—multimodality hallucinations—or on 
different occasions).62 In Oorschot et  al’s57 sample of 
individuals with mixed psychosis, VHs occurring alone 
were rarer than auditory hallucinations occurring alone. 
As shown in table 1, auditory hallucinations predominate 
over VH in terms of their relative prevalence.
Hallucinations in multiple modalities have also been 
noted in individuals with severe depression63 and with 
mixed psychiatric diagnoses,64 as well as in nonclinical 
adults and adolescents (n  =  355, 11–13  years).65 Such 
co-occurrences of auditory/VHs suggest a common hal-
lucinatory mechanism which, in combination with spe-
cific sensory dysfunctions, determines the modality of 
hallucinations.
Table 3. The Comparative Prevalence of Visual Hallucinations and Auditory Hallucinations in the General Community (A) and After 
Excluding Hallucinations Arising From Drug-Taking or Physical Illness (B)
n Visual Hallucinations (%)
(A) General population
 Eaton et al (1991)39 810 8
 Tien (1991)40 18 572 14
 Ohayon (2000)41 13 057  3.2
 Waters et al (2003)42 562 (university students) 10
 Larøi and Van der Linden (2005)43 236 (university students) 32
 Kessler et al (2005)44 9282 6.3
Total: 6 studies, n = 42 519 Weighted mean = 7.35%
SD = 5.08
(B) Excl drug-taking and physical illness
 Eaton et al (1991)39 810 4
 Tien (1991)40 18 572 7
 Van Os et al (2000)45 7076 2–6
Total: 3 studies, n = 26 458 participants Weighted mean = 6%
SD: 1.73
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It is important to note, however, that “simultaneous” 
(or “fused”) auditory and VHs are not a frequent occur-
rence.16 In most cases, they are experienced at different 
times (eg, an auditory hallucination one day and a VH the 
next). Furthermore, when simultaneous auditory/VHs do 
occur, they are typically unrelated66 (eg, seeing the devil 
while hearing the voice of a relative inside one’s head), 
suggesting that the mechanisms for auditory and VHs in 
these disorders must be partly independent, though with 
some overlap.
By contrast, a different pattern can be observed in 
organic disease. In PD, VHs predominate over audi-
tory hallucinations,67 and in CBS, the absence of  hallu-
cinations in other modalities is a diagnostic criterion. 
Where eye disease co-occurs with dementia, auditory 
hallucinations and delusions may appear as the demen-
tia progresses, as is the case in PD68 or dementia alone.69 
In these disorders, auditory and VHs very rarely occur 
at the same time.
Overall, the relative proportion of auditory to visual 
modality hallucinations seems to differentiate the psy-
chosis spectrum from organic conditions.
Phenomenological Features of VH
Psychosis
There are few systematic or comprehensive studies of 
VH as dimensional experiences in psychosis. Exceptions 
include Goodwin et  al,16 Gauntlett and Kuipers,64 and 
Dudley et al.70 For the following review, information was 
drawn from these and other studies.12,16,28,53,62,71,72
Perceptual Qualities. VHs in psychosis are reported to 
have the physical properties of real perceptions. They are 
often life-sized, detailed, and solid. They are projected 
into the external world in most cases and are typically 
“anchored in external space,” either just beyond the reach 
of individuals or further away. VHs often have 3 dimen-
sional shapes, with depth and shadows, and distinct 
edges. VH can be colorful or in black and white. Images 
are often described as dynamic with the contents chang-
ing in size, shape, and movement but may also be static.
Temporal Aspects. The frequency of hallucinatory epi-
sodes varies from rare to frequent, and episodes can last 
several seconds to several minutes. VH may be experi-
enced during both day and night.
Content. Fully formed VHs are more common than 
unformed visual experiences and distortions. Complex 
VHs often comprise images of people (walking, family), 
faces, animals, objects, or events (eg, visions of fires) tak-
ing place in front of the individual. In contrast to hal-
lucinations in organic conditions, a common theme is of 
visions with frightening content (bugs, dogs, snakes, dis-
torted faces), and these are linked to distress. Unlike VH 
in PD, visions of dead people are rare, although visions 
of God, angels, the devil, saints, and fairies are common.
Reality. VHs are perceived to be real and “definitely 
present” in a concrete sense. In further support for the 
subjective reality of the experience, a majority of indi-
viduals undertake some activity directly related to the 
vision—such as moving toward the vision, hitting at the 
vision, or moving away. In the case of distressing images, 
individuals may act to keep themselves safe.
Sense of Control. A lack of control over the content 
and appearance is a prominent feature of VH in psycho-
sis. Individuals are surprised when VHs occur and are 
generally helpless to change or stop them. In general, 
individuals believed that visions are experienced only by 
themselves.
Onset and Triggers. The onset of VH has been linked 
to stress, tiredness, loneliness, and relationship problems 
in psychiatric individuals. Other psychological triggers 
include negative emotions, and they may co-vary with 
levels of anxiety.
Reactions. A  mixture of positive and negative images 
may be experienced. Reactions vary and can include plea-
sure, happiness and reassurance, or indifference. Images 
can also evoke fright, depression, sadness, or hopeless-
ness. While the content of  VH is often impersonal or 
unrelated to the person, images are often interpreted to 
have personal implications. Many individuals believe that 
the content of visions must be acted upon, for fear of a 
negative event occurring as a consequence. This differs 
from hallucinations in organic conditions, where VHs are 
not generally perceived to be real.
Beliefs and Appraisals. VHs may be believed to arise 
from an external source, particularly of supernatural 
origin. Images of powerful religious figures are often 
perceived to be visions intended as a sign for the person 
to act and as a threat to their physical or psychological 
wellbeing. This can also impact on the individual’s belief  
system and can be used as evidence for their delusional 
beliefs.
Overall, such rich phenomenology of VH in psycho-
sis points to true hallucinatory experiences and not only 
misperceptions. This close examination of VH character-
istics also reveals remarkable similarities with auditory 
hallucinations with regards perceptual quality, contents, 
lack of control, beliefs, appraisals, and reactions.
With regards a comparison with organic disorders, 
broadly speaking, the form and character of VH in psy-
chosis is similar to those seen in eye disease and neuro-
degeneration. Although there is a notable lack of studies 
making direct comparisons, there are several character-
istics that distinguish VH in psychotic disorders from 
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other disorders, namely frightening contents, emotional 
reactions, and appraisals of personal significance; a lack 
of illusions (common in neurodegenerative disease) and 
simple VHs (common in eye disease) also differ.
Subclinical Symptoms in the General Community
Nonclinical individuals in the community report vivid 
VH, where objects are real and uncontrollable, but often 
of brief  duration.73 The features of VH in nonclinical 
samples are broad-ranging and include unformed VH 
(such as dots, flashes of light and other unformed shapes) 
and formed VH (people and faces, but also aliens).65 In 
contrast to VH in psychosis, hallucinated images in non-
clinical populations are less likely to involve complex 
scenes but more likely to show people.52
These VH clinical features are similar to that of audi-
tory hallucinations in nonclinical populations, which 
also tend to be brief  and mostly neutral or pleasant in 
content.74 
Eye Disease and Neurodegenerative Conditions
For comparison with the above, the most detailed 
accounts of visual content are found in the eye disease 
literature (CBS).75 The commonest contents are of simple 
hallucinations, followed by images of people or animals 
(50%–80%), patterns (55%), faces often described as 
grotesque and cartoon-like (40%), landscapes or inani-
mate objects (20%). They are usually colorful. Unlike 
in psychosis, VHs in CBS are not generally perceived to 
be real or to have personal meaning. Only in a third of 
the cases is the content negative. Once individuals under-
stand they are a common feature of poor vision, anxiety 
about VH generally decreases. This differs from psycho-
sis, where lack of insight may contribute to distress about 
these experiences. Other dimensional features related to 
clarity, frequency, temporal factors, and appearance are 
similar to those in psychosis.76 In PD, VHs mostly con-
sist of people who may be familiar or not, and alive or 
deceased (73%), animals (33%), and objects (19%) which 
may appear briefly and move sideways (passage halluci-
nation).49 The contents are fairly stereotyped and repeti-
tive but may last for hours at a time. Experiences appear 
to be real and outside voluntary control but are not often 
perceived as frightening. In dementia, VHs tend to be of 
fairly mundane content, including unfamiliar or small 
figures, faces, animals, and objects/machines, and are 
rarely distressing.69
Figure  1 (adapted from ffytche77) provides an over-
view of VH in different clinical settings, where a range 
of clinical conditions (columns) are cross-tabulated with 
VH content and related phenomena (rows). Comparing 
the phenomenology of VH in psychosis with other condi-
tions suggests that they are most similar to VH in cortical 
Fig. 1. Visual perceptual symptoms and their clinical contexts.77 A range of clinical conditions (columns) are cross-tabulated with visual  
hallucination (VH) content and related phenomena (rows). For each condition, the percentage of individuals with VHs reporting a  
given content is coded red (>20%), pink (10%–20%), or white (not reported or < 10%). The prevalence of each symptom in psychosis  
is taken from.64 For auditory hallucinations, (+) indicates higher prevalence than VH and (−) indicates lower prevalence than VH  
(figure adapted from ffytche77). Visual experiences in schizophrenia best match the phenomena reported in the red box derived from  
PD, AD, DLB, and peduncular lesions—but not the green (eye and visual pathway pathology) and blue (serotonergic syndrome) boxes. 
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and subcortical disorders (red box) but differ in the rela-
tive predominance of auditory and VHs. Whether this is 
an important neurobiological distinction is unclear, and 
the boundary of the grouping has been left open as indi-
cated by the dashed line.
The Assessment of VHs
It is often difficult to distinguish VH from related visual 
phenomena such as illusions, distortions, and mispercep-
tions that co-occur with VH in psychosis and other con-
ditions. The relationship between what is seen and what is 
actually present in the environment is complex and poorly 
understood with internal models and top-down inference 
interacting with visual inputs. The match between what 
is perceived and what is present is closest for veridical 
perception (our day-to-day visual perceptual experience), 
tenuous for illusions, and absent for hallucinations; how-
ever, there are no sharp dividing lines between categories. 
Based on a working definition of hallucinations,78 the key 
features to elicit in an assessment of VH are (see Box 1):
1. They must be experienced in full consciousness (rules 
out sleep-related VH, fever, delirium, and hypnosis).
2. Not elicited by an external stimulus (excludes visual 
distortions and illusions).
3. The experience has a sense of reality to resemble a 
veridical perception (must have physical properties of 
real perceptions and be located in external space; note 
that this does not mean that VH must be perceived to 
be real or that insight must be lacking).
4. The subject does not feel s/he has direct and voluntary 
control (rules out visual imagery).
Cognition
Cognitive processes of VH in psychosis have rarely been 
investigated. In organic disorders, hallucinations are 
held to reflect disorders within distributed perceptual 
systems. The Perceptual and Attentional Deficit model 
advocates for a combination of impaired visual process-
ing and attention in VH in neurodegenerative disorders 
and eye disease.80 Diederich et  al’s81 contemporaneous 
PD-developed interactive model similarly proposes a 
combination of poor visual input and processing with 
defective central visual monitoring. More recently, Shine 
et  al’s Attentional model82 proposes that hallucinations 
occur in PD when there is underactivity in dorsal atten-
tional networks in the presence of ambiguous percepts. 
Each of these models, therefore, proposes that combined 
attentional and visual perceptual problems lead to VH.
In psychosis, however, perceptual processes are usu-
ally believed to be intact or even overactive. It has been 
suggested that VH in psychosis may be best understood 
in terms of the intrusion into awareness of subconscious 
images or highly vivid mental imagery, as modulated by 
Box 1. A Diagnostic Algorithm for Visual 
Hallucinations and Related Phenomena79
Question 1: Are the visual phenomena experienced (a) 
during sleep, (b) on the border of waking and sleeping, 
or (c) while awake?
a) During sleep
 Rule out: dream
 Possibility 1: incubus phenomenon
 Possibility 2: visual sleep start
b) On the border of waking and sleeping
  Possibility 1: hypnagogic hallucination 
Possibility 2: hypnopompic hallucination
c) While awake
 Go to Question 2
Question 2: Are the visual phenomena perceptual in 
nature? (ie, with physical properties comparable with 
sensory perceptions)
No Rule out: imagery
Yes Continue with Question 3
Question 3: Do they constitute (a) images without a 
representation in the outside world, (b) images with a 
representation in the outside world, or (c) distortions?
 a) Without representation in the outside world (visual 
hallucinations):
  Go to Question 4
 b) With a representation in the outside world (visual 
illusions): 
  Go to Question 5
Distortions (metamorphopsias): 
  Go to Question 6
Question 4: Are the hallucinations (a) simple in nature, 
(b) geometric, (c) complex, or (d) compound (ie, mul-
timodal) in nature?
a) Simple hallucinations
  Rule out: physiological phenomena such as 
blue-field entoptic phenomenon, macular star 
pattern, or mouches volantes (uncomplicated)
 Determine: type and context
b) Geometric hallucinations
 Determine: type and context
c) Complex hallucinations
 Determine: type and context
d) Compound hallucinations
  Determine: type (ie, sensory modalities) and 
context
Question 5: Are the illusions attributable to (a) physical 
reality, (b) the perceptual system, or (c) mental associations?
a) Physical illusions
  Determine: type and context (never 
pathological!)
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personal, social, or psychological variables.58 In support, 
an increase in the salience of imagery has been found 
in schizophrenia individuals with VH.45 Other cognitive 
deficits found in psychotic VH include source-monitoring 
impairments, such as difficulties making internal/external 
and self/other discriminations83 and confusion regarding 
whether the source of material was real or imagined.84 
Such source-monitoring deficits are also commonly 
found in auditory hallucinations85 and may lead to these 
events being believed as real.
Personal, social, and cultural contributors to VH have 
not yet been systematically investigated, although top-
down mechanisms (which include expectations, personal 
meaning-making, and social context) may influence 
dynamic attentional processes by biasing the competi-
tion between potential perceptions toward objects and 
persons that have personal and social relevance. In sup-
port for this view, stress and bereavement are linked to 
the onset of VH. Further support comes from cognitive 
models of psychosis78 that propose that key influences 
of personal events, social/cultural context, and expecta-
tions have the ability to activate percepts in the absence 
of external stimulation.
Altogether, mechanisms of VH in psychosis are not 
well understood. Interesting similarities with the litera-
ture on auditory hallucination exist, including source-
monitoring deficits and the strong influence of top-down 
mechanisms. By contrast, evidence for visual processing 
difficulties which feature strongly in models of VH in the 
organic literature77 is lacking.
Brain Imaging and Electrophysiology
In the field of psychosis, a study conducted in individuals 
with first-episode psychosis (n = 15 with VH) showed per-
hallucinatory activity within visual association cortex, 
while the vividness of VH was linked to activity within 
the primary visual cortex.86 Activity in the visual asso-
ciation cortex during VH has also been demonstrated in 
single case studies in schizophrenia.87,88 Concerning the 
organic literature, dysfunctions of higher visual process-
ing areas during or between VH episodes have been found 
in Alzheimer’s disease,89 DLB,90,91 and CBS92 within the 
ventral and the dorsal visual pathways involved in object 
recognition and visuospatial memory93,94 as well as the 
frontal lobes.95 Furthermore, structural changes in these 
areas were independent of cognitive function and age.96 
Overall, symptom-capture studies in these populations 
showed that the location of the per-VH activity corre-
lated with the phenomenological content of the halluci-
natory experiences (ie, color-specialized cortex if  in color, 
face-specialized cortex if  faces are experienced, etc).
Connectivity studies have much relevance for the 
study of VH, given that dysconnectivity is a prominent 
model for psychosis, which could also apply to specific 
symptoms such as hallucinations.97 The dysconnectivity 
hypothesis suggests that the existence of impaired con-
nectivity between different brain regions is responsible 
for abnormal functional integration within neural net-
works. In support for dysconnectivity, using diffusion 
tensor imaging, Ashtari and collaborators showed that 
adolescents suffering from early-onset schizophrenia 
with a history of VH exhibited lower fractional anisot-
ropy, potentially reflecting a loss in white matter integrity, 
in the left inferior longitudinal fasciculus which connects 
temporal and occipital cortices, when compared with 
individuals without VH.98
The hippocampal complex (HC) is also of considerable 
interest with regards to VH in both neurodegeneration 
and psychosis. The HC has been shown to be atrophied in 
individuals with PD and VH,99 and it appears to occupy 
a key place within the networks involved in VH in psy-
chosis.100 For example, a recent multimodal connectivity 
study, combining functional connectivity, tract-based 
spatial statistics, and shape analysis of the HC, con-
firmed differential connectivity patterns of this structure 
in individuals with schizophrenia. Moreover, this abnor-
mal connectivity depends on the sensory-modality of 
hallucinatory experiences involved and was particularly 
obvious with visual areas in patients with VH.97 In addi-
tion, a symptom-capture study of VH in schizophrenia87 
reported cortical activity in the HC, although this was 
not reported in CBS.92
A particular subtype of functional connectivity stud-
ies focuses on spontaneous fluctuations at rest. It has 
already been used in the field of auditory hallucinations 
to test the hypothesis of disrupted intrinsic connectivity as 
a pathological mechanism.101 Jardri and colleagues’ study 
confirmed a dynamic interaction between association sen-
sory cortices and the default-mode network (DMN) for 
patients with multisensory hallucinations, including VH.86 
Sensory and DMN networks were found to be anticorre-
lated during the experience of hallucinations; furthermore, 
the DMN spatial and temporal instability persisted during 
non-hallucinatory periods.86 Impaired interactions with 
the DMN have also been suggested in the pathophysiology 
of VH in PD,82 but contrary to what has been proposed in 
first-episode psychosis in which the DMN seems primarily 
b) Physiological illusions
 Determine: type and context
c) Cognitive illusions
 Determine: type and context
Question 6: Do the distortions have (a) a peripheral or 
(b) a central origin?
a) Peripheral metamorphopsias
 Determine: type and context
b) Central metamorphopsias
 Determine: type and context
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and intrinsically affected, these authors proposed an exter-
nal DMN interference through aberrant interactions with 
ventral and dorsal attentional networks.
Fewer studies have investigated the electrophysiology 
of VH. Spencer and colleagues found reduced visual cor-
tex activation as measured by a negative evoked potential 
component (NI) and increased gamma band phase lock-
ing associated with VH in schizophrenia, consistent with 
an underlying visual cortical hyperexcitability and reduced 
responsiveness to external visual stimulation in this sub-
group.102 Indices of hyperexcitability and reduced respon-
siveness have also been found in PD (a delayed P100 evoked 
potential component)103 and post-lysergic acid diethylamide 
VH (occipital theta coherence).104 The electrophysiology of 
VH capture is consistent with brain imaging studies in sug-
gesting activation of visual association cortex as measured 
by coherence105 or theta/alpha desynchronization.106
Comparative Psychopathology
What are the implications of the similarities and differ-
ences between VH in psychosis spectrum, eye and neuro-
degenerative disease outlined above? It is clear that there 
is an absence of evidence in many areas, and that direct 
comparative work is required. VHs in psychosis most 
closely resemble VH in neurodegeneration, and the asso-
ciation of auditory and VHs in these conditions suggests 
the 2 modalities of hallucination share a common patho-
physiological mechanism. Dysfunctions in attentional and 
executive/top-down mechanisms are also common in both 
neurodegenerative and psychotic conditions, as are occipi-
tal cortex and HC involvement during hallucinations.
However, the differing predominance of auditory and 
visual modalities in neurodegenerative disease and psy-
chosis, the phenomenological differences at the levels 
of emotional reactions and appraisals, and the differing 
dysconnectivity and visual processing profiles suggest 
there are also important differences. Perhaps the same 
pathological mechanism has differential effects on the 
visual and auditory systems in psychosis and neurode-
generative disease, depending on the presence/absence 
of specific co-occurring sensory dysfunctions. Such com-
parative insights have potentially important implications 
for treating VH as they provide a rationale for import-
ing approaches found effective in one clinical context to 
another.
Treatment Approaches
Cognitive Behavioral Therapy
Cognitive behavioral therapy has an established, though 
modest, evidence base for the treatment of psychosis 
(referred to as CBTp). However, evidence for its use in 
VH rests mainly on case studies.
Recently, O’Brien and Johns107 described an individual 
who had visions of snakes and who held beliefs that she 
was at risk of harm from these snakes. CBT that included a 
graded exposure approach to help reduce fear and escape 
reaction showed some benefit which was maintained at 3 
months. Whether this is helpful with other visual experi-
ences is unclear, although studies show that the apprais-
als and beliefs should be a core target for treatment.70,108
Collerton and Dudley109 developed a model drawn 
from a cognitive model of  auditory hallucinations and 
panic and which targets appraisal and reactions to VH. 
Given that avoidance, escape and safety-seeking behav-
iors are common but unhelpful strategies, the aim of 
treatment is for people to recognize that they are safe, 
and that the fear may be real but the danger is not. The 
therapy includes psychoeducation about VH, reality 
testing and normalization, as well as understanding of 
triggers. Imagery exposure and transformation strategies 
are used to attempt control over the experience. A case 
series (under review) describes the use of  this treatment 
approach in 4 people with psychosis with distressing VH.
Overall, evidence for the effectiveness of CBT for VH 
is limited. The treatment of VH may be improved by 
addressing trauma and stress as a key feature of VH pre-
sentation, and with the development of sensitive and spe-
cific outcome measures that match the goals of treatment.
The Pharmacological Management of VH
There is limited evidence for specific pharmacological 
treatments for VH in psychosis. Antipsychotics are typi-
cally used, but some studies have reported that VHs were 
not linked to treatment effects28,110 or even that VHs may 
be a marker of neuroleptic resistance.10 Clozapine has 
been reported as effective for VH in PD,111 but studies in 
schizophrenia are lacking.
The literature drawn from organic disease suggests the 
different approaches that might be considered. For exam-
ple, for individuals with visual impairment, treatment of 
the eye condition can reduce the risk of VH.112 The case 
report literature has highlighted a range of medications 
that may help reduce VH, but there is currently a lack of 
clinical trial data. For example, drugs increasing cholinergic 
activity are thought to reduce the risk for VH. The AchE-I 
(rivastigmine, donepezil, and galantamine) are beneficial 
when treating behavioral and psychological symptoms of 
dementia113 and PD114 and have been reported to help in 
schizophrenia.114 Other drugs have been used in organic 
conditions (antidepressants, memantine, or anticonvul-
sants) but have not been examined in psychosis.
In sum, there is a lack of systematic studies, but this 
overview suggests new possibilities for treating VH in 
psychosis.
Conclusion
Altogether, this article reviewed the available evidence on 
the prevalence, phenomenology, clinical characteristics, 
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assessment methods, cognition, brain imaging, electro-
physiology, and treatment approaches for VH in the psy-
chosis spectrum.
There are significant potential benefits to making direct 
comparisons of VH in organic and psychotic illness. These 
include informing our understanding and theoretical models 
of VH in schizophrenia and across diagnostic categories, 
informing hypothesis-driven questions for research, and 
suggesting new possibilities for therapeutic interventions.
This is the first review of VH in psychosis to incor-
porate data using different methodological perspectives 
and different population groups. One open question is 
whether VHs in psychosis have the same pathological 
mechanisms as VH in eye or organic conditions. From 
the evidence, it is clear that they are not as closely asso-
ciated as they might appear. They show some similari-
ties in clinical presentation and form, and in cognitive 
mechanisms, but differences in age, emotional content 
and appraisal, pathological profile, and neuroimaging 
findings might argue for different causal pathways. There 
is also little evidence one way or the other on whether 
visual perception in psychosis is as impaired as it is in 
other disorders.
This review also aided our understanding of hallu-
cinations across different modalities, and particularly 
auditory hallucinations. As seen above, auditory hal-
lucinations and VH frequently co-occur, although not 
necessarily simultaneously. One possibility suggests a 
set of core pathological mechanisms in addition to spe-
cific modality-dependent dysfunctions. Alternatively, the 
same pathological mechanism has differential effects on 
the visual and auditory systems in psychosis and neuro-
degenerative disease, depending on the presence/absence 
of specific co-occurring sensory dysfunctions. Clearly, 
direct comparisons are needed testing the compatibility 
of theoretical models developed in the 2 modalities of 
hallucinations (see key future directions in table 4).
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